Skip to main content
SpringerLink
Log in

Calcium Channel Block and Inactivation

Insights from Structure-Activity Studies

  • Chapter
Voltage-Gated Calcium Channels

Part of the book series: Molecular Biology Intelligence Unit ((MBIU))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Stotz SC, Zamponi GW. Structural determinants of fast inactivation of high voltage-activated Ca2+ channels. Trends Neurosci 2001; 24:176–181.

    Article  PubMed  CAS  Google Scholar 

  2. Hering S, Berjukow S, Sokolov S et al. Molecular determinants of inactivation in voltage-gated Ca2+ channels. J Physiol 2000; 528:237–249.

    Article  PubMed  CAS  Google Scholar 

  3. Ertel EA, Campbell KP, Harpold MM et al. Nomenclature of voltage-gated calcium channels. Neuron 2000; 25:533–535.

    Article  PubMed  CAS  Google Scholar 

  4. Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu Rev Cell Dev Biol 2000; 16:521–555.

    Article  PubMed  CAS  Google Scholar 

  5. Striessnig J, Grabner M, Mitterdorfer J et al. Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci 1998; 9:108–115.

    Article  Google Scholar 

  6. Walker D, De Waard M. Subunit interaction sites in voltage-dependent Ca2+ channels: Role in channel function. Trends Neurosci 1998; 21(4):148–154.

    Article  PubMed  CAS  Google Scholar 

  7. Stea A, Tomlinson WJ, Soong TW et al. Localization and functional properties of a rat brain alpha 1A calcium channel reflect similarities to neuronal Q-and P-type channels. Proc Natl Acad Sci USA 1994; 91:10576–10580.

    Article  PubMed  CAS  Google Scholar 

  8. Birnbaumer L, Qin N, Olcese R et al. Structures and functions of calcium channel beta subunits. J Bioenerg Biomembr 1998; 30:357–375.

    Article  PubMed  CAS  Google Scholar 

  9. Boyett MR, Honjo H, Harrison SM et al. Ultra-slow voltage-dependent inactivation of the calcium current in guinea-pig and ferret ventricular myocytes. Pflugers Arch 1994; 428(1):39–50.

    Article  PubMed  CAS  Google Scholar 

  10. Hering J, Maulet Y, Feltz A et al. Slow inactivation of the Cav3.1 isoform of the T-type channel. Biophys J 2001; 80(1)p2:621a.

    Google Scholar 

  11. Sokolov S, Weiss RG, Timin EN et al. Modulation of slow inactivation in class A Ca2+ channels by beta-subunits. J Physiol 2000; 527(3):445–454.

    Article  PubMed  CAS  Google Scholar 

  12. Degtiar VE, Scheller RH, Tsien RW. Syntaxin modulation of slow inactivation of N-type calcium channels. J Neurosci 2000; 20(12):4355–4367.

    PubMed  CAS  Google Scholar 

  13. Qin N, Olcese R, Bransby M et al. Ca2+-induced inhibition of the cardiac Ca2+ channel depends on calmodulin. Proc Natl Acad Sci USA 1999; 96:2435–2438.

    Article  PubMed  CAS  Google Scholar 

  14. Lee A, Wong ST, Gallagher D et al. Ca2+/Calmodulin binds to and modulates P/Q-type calcium channels. Nature 1999; 399:155–159.

    Article  PubMed  CAS  Google Scholar 

  15. Peterson BZ, DeMaria CD, Yue DT. Calmodulin is the Ca2+ sensor for Ca2+-dependet inactivation of L-type calcium channels. Neuron 1999; 22:549–558.

    Article  PubMed  CAS  Google Scholar 

  16. Zuhlke RD, Pitt GS, Deisseroth K et al. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature 1999; 399:159–162.

    Article  PubMed  CAS  Google Scholar 

  17. Erickson MG, Alseikhan BA, Peterson BZ et al. Preassociation of calmodulin with voltage-gated Ca2+ channels revealed by FRET in single living cells. Neuron 2001; 31(6):973–985.

    Article  PubMed  CAS  Google Scholar 

  18. Lee KS, Tsien RW. Mechanism of calcium channel blockade by verapamil, D600, diltiazem and nitrendipine in single dialysed heart cells. Nature 1983; 302(5911):790–794.

    Article  PubMed  CAS  Google Scholar 

  19. McDonald TF, Pelzer D, Trautwein W. Cat ventricular muscle treated with D600: Characteristics of calcium channel block and unblock. J Physiol 1984; 352:217–241.

    PubMed  CAS  Google Scholar 

  20. Bean BP. Nitrendipine block of cardiac calcium channels: High-affinity binding to the inactivated state. Proc Natl Acad Sci USA 1984; 81:6388–6392.

    Article  PubMed  CAS  Google Scholar 

  21. Sanguinetti MC, Kass RS. Voltage-dependent block of calcium channel current in the calf cardiac purkinje fibre by dihydropyridine calcium channel antagonists. Circ Res 1984; 55:336–348.

    PubMed  CAS  Google Scholar 

  22. Bezprozvanny I, Tsien RW. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967). Mol Pharmacol 1995; 48(3):540–549.

    PubMed  CAS  Google Scholar 

  23. Aczel S, Kurka B, Hering S. Mechanism of voltage-and use-dependent block of class A Ca2+ channels by mibefradil. Br J Pharmacol 1998; 125(3):447–454.

    Article  PubMed  CAS  Google Scholar 

  24. Grabner M, Wang Z, Hering S et al. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron 1996; 16(1):207–218.

    Article  PubMed  CAS  Google Scholar 

  25. Hering S, Aczel S, Grabner M et al. Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. J Biol Chem 1996; 271(40):24471–24475.

    Article  PubMed  CAS  Google Scholar 

  26. Motoike HK, Bodi I, Nakayama H et al. A region in IVS5 of the human cardiac L-type calcium channel is required for the use-dependent block by phenylalkylamines and benzothiazepines. J Biol Chem 1999; 274(14):9409–9420.

    Article  PubMed  CAS  Google Scholar 

  27. Degtiar VE, Aczel S, Doring F et al. Calcium channel block by (−)devapamil is affected by the sequence environment and composition of the phenylalkylamine receptor site. Biophys J 1997; 73(1):157–167.

    PubMed  CAS  Google Scholar 

  28. Hering S, Aczel S, Kraus RL et al. Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: Role of inactivation. Proc Natl Acad Sci USA 1997; 94(24):13323–13328.

    Article  PubMed  CAS  Google Scholar 

  29. Sokolov S, Weiss RG, Kurka B et al. Inactivation determinant in the I–II loop of the Ca2+ channel α1-subunit and beta-subunit interaction affect sensitivity for the phenylalkylamine (−)gallopamil. J Physiol 1999; 519(2):315–322.

    Article  PubMed  CAS  Google Scholar 

  30. Jimenéz C, Bourinet E, Leuranguer V et al. Determinants of voltage-dependent inactivation affect mibefradil block of calcium channels. Neuropharmacology 2000; 39:1–10.

    Article  PubMed  Google Scholar 

  31. Lacinova L, Ludwig A, Bosse E et al. The block of the expressed L-type calcium channel is modulated by the beta 3 subunit. FEBS Lett 1995; 373:103–107.

    Article  PubMed  CAS  Google Scholar 

  32. Sokolov S, Timin E, Hering S. On the role of Ca2+-and voltage-dependent inactivation in Cav1.2 sensitivity for the phenylalkylamine (−)gallopamil. Circ Res 2001; 89:700–708.

    PubMed  CAS  Google Scholar 

  33. Zamponi GW, Soong TW, Bourinet E et al. Beta subunit coexpression and the alpha1 subunit domain I–II linker affect piperidine block of neuronal calcium channels. J Neurosci 1996; 6:2430–2443.

    Google Scholar 

  34. Berjukow S, Marksteiner R, Gapp F et al. Molecular mechanism of calcium channel block by isradipine. Role of a drug-induced inactivated channel conformation. J Biol Chem 2000; 275:22114–22120.

    Article  PubMed  CAS  Google Scholar 

  35. Berjukow S, Hering S. Voltage-dependent acceleration of Cav1.2 channel current decay by (+)-and (−)-isradipine. Br J Pharmacol 2001; 133(7):959–966.

    Article  PubMed  CAS  Google Scholar 

  36. Hille B. Local anaesthetics: Hydrophilic and hydrophobic pathways for drug-receptor action. J Gen Physiol 1977; 69:497–515.

    Article  PubMed  CAS  Google Scholar 

  37. Timin EN, Hering S. A method for estimation of drug affinity constants to the open conformational state of calcium channels. Biophys J 1992; 63(3):808–814.

    Article  PubMed  CAS  Google Scholar 

  38. Hering S. β-Subunits: Fine tuning of calcium channel block Trends Pharmacol Sci 2002; in press.

    Google Scholar 

  39. Hering S, Berjukow S, Aczel S et al. Ca2+ channel block and inactivation: Common molecular determinants. Trends Pharmacol Sci 1998; 19:439–443.

    Article  PubMed  CAS  Google Scholar 

  40. Hockerman GH, Dilmac N, Scheuer T et al. Molecular determinants of diltiazem block in domains IIIS6 and IVS6 of L-type Ca2+ channels. Mol Pharmacol 2000; 58(6):1264–1270.

    PubMed  CAS  Google Scholar 

  41. Kraus RL, Hering S, Grabner M et al. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels. J Biol Chem 1998; 273(42):27205–27212.

    Article  PubMed  CAS  Google Scholar 

  42. Berjukow S, Gapp F, Aczel S et al. Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. J Biol Chem 1999; 274(10):6154–6160.

    Article  PubMed  CAS  Google Scholar 

  43. Shi C, Soldatov NM. Molecular determinants of voltage-dependent slow inactivation of the Ca2+ channel. J Biol Chem 2002; 277(9):6813–6821.

    Article  PubMed  CAS  Google Scholar 

  44. Berjukow S, Marksteiner R, Sokolov S et al. Amino acids in segment IVS6 and β-subunit interaction support distinct conformational changes during Cav2.1 inactivation. J Biol Chem 2001; 276:17076–17082.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Biochemische Pharmakologie, Peter Mayr Straße 1, Innsbruck, Austria

    Steffen Hering, Stanislav Sokolov, Stanislav Berjukow, Rainer Marksteiner & Eva Margreiter

  2. Vishnevski Institute of Surgery Moscow, Moscow, Russia

    Evgeni N. Timin

Authors
  1. Steffen Hering
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stanislav Sokolov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stanislav Berjukow
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rainer Marksteiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eva Margreiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Evgeni N. Timin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Eurekah.com and Kluwer Academic / Plenum Publishers

About this chapter

Cite this chapter

Hering, S., Sokolov, S., Berjukow, S., Marksteiner, R., Margreiter, E., Timin, E.N. (2005). Calcium Channel Block and Inactivation. In: Voltage-Gated Calcium Channels. Molecular Biology Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-27526-6_18

Download citation

Publish with us

Policies and ethics

Search

Navigation